These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32154946)

  • 1. Plasma Short-Chain Fatty Acids in Patients With Parkinson's Disease.
    Shin C; Lim Y; Lim H; Ahn TB
    Mov Disord; 2020 Jun; 35(6):1021-1027. PubMed ID: 32154946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's Disease Is Associated with Impaired Gut-Blood Barrier for Short-Chain Fatty Acids.
    Yang X; Ai P; He X; Mo C; Zhang Y; Xu S; Lai Y; Qian Y; Xiao Q
    Mov Disord; 2022 Aug; 37(8):1634-1643. PubMed ID: 35607987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.
    Wu G; Jiang Z; Pu Y; Chen S; Wang T; Wang Y; Xu X; Wang S; Jin M; Yao Y; Liu Y; Ke S; Liu S
    BMC Neurol; 2022 Jan; 22(1):13. PubMed ID: 34996385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson's Disease.
    He X; Qian Y; Xu S; Zhang Y; Mo C; Guo W; Yang X; Xiao Q
    J Parkinsons Dis; 2021; 11(3):1167-1176. PubMed ID: 33935107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
    Aho VTE; Houser MC; Pereira PAB; Chang J; Rudi K; Paulin L; Hertzberg V; Auvinen P; Tansey MG; Scheperjans F
    Mol Neurodegener; 2021 Feb; 16(1):6. PubMed ID: 33557896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.
    Chen SJ; Chen CC; Liao HY; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    J Parkinsons Dis; 2022; 12(4):1219-1230. PubMed ID: 35342048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired gut barrier integrity and reduced colonic expression of free fatty acid receptors in patients with Parkinson's disease.
    Liao PH; Tung HY; Lim WS; Jang JR; Li H; Shun CT; Chiu HM; Wu MS; Lin CH
    Neurol Sci; 2024 Nov; 45(11):5297-5307. PubMed ID: 38862654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
    Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
    Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson's disease after dietary supplementation with branched-chain amino acids.
    Mi N; Ma L; Li X; Fu J; Bu X; Liu F; Yang F; Zhang Y; Yao L
    Open Med (Wars); 2023; 18(1):20230849. PubMed ID: 38045857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-Analysis of Gut Dysbiosis in Parkinson's Disease.
    Nishiwaki H; Ito M; Ishida T; Hamaguchi T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Shimamura T; Mori H; Kurokawa K; Katsuno M; Hirayama M; Ohno K
    Mov Disord; 2020 Sep; 35(9):1626-1635. PubMed ID: 32557853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Metabolic Analysis Reveals the Dysregulation of Short-Chain Fatty Acid Metabolism in Parkinson's Disease.
    Qi A; Liu L; Zhang J; Chen S; Xu S; Chen Y; Zhang L; Cai C
    Mol Neurobiol; 2023 May; 60(5):2619-2631. PubMed ID: 36690885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fiber from a regular diet is directly associated with fecal short-chain fatty acid concentrations in the elderly.
    Cuervo A; Salazar N; Ruas-Madiedo P; Gueimonde M; González S
    Nutr Res; 2013 Oct; 33(10):811-6. PubMed ID: 24074739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
    Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
    Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GC-MS Analysis of Short-Chain Fatty Acids in Feces, Cecum Content, and Blood Samples.
    Hoving LR; Heijink M; van Harmelen V; van Dijk KW; Giera M
    Methods Mol Biol; 2018; 1730():247-256. PubMed ID: 29363078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HiSorb sorptive extraction for determining salivary short chain fatty acids and hydroxy acids in heart failure patients.
    Lenzi A; Biagini D; Ghimenti S; Vivaldi FM; Salvo P; Di Francesco F; Lomonaco T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123826. PubMed ID: 37481789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.